Barrett & Company’s Idexx Laboratories IDXX Stock Holding History

Barrett & Company’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$382K	Buy	725 +635	+706%	+$356K	0.11%	110
2026 Q1	$50.6K	Hold	90	–	–	0.02%	287
2025 Q4	$60.9K	Hold	90	–	–	0.02%	271
2025 Q3	$57.5K	Hold	90	–	–	0.02%	277
2025 Q2	$48.3K	Hold	90	–	–	0.02%	298
2025 Q1	$37.8K	Hold	90	–	–	0.02%	303
2024 Q4	$37.2K	Hold	90	–	–	0.02%	309
2024 Q3	$45.5K	Sell	90 -70	-44%	-$34K	0.02%	278
2024 Q2	$78K	Hold	160	–	–	0.04%	218
2024 Q1	$86.4K	Hold	160	–	–	0.04%	213
2023 Q4	$88.8K	Hold	160	–	–	0.05%	204
2023 Q3	$70K	Hold	160	–	–	0.04%	216
2023 Q2	$80.4K	Buy	160 +40	+33%	+$19.2K	0.05%	210
2023 Q1	$60K	Hold	120	–	–	0.04%	228
2022 Q4	$49K	Hold	120	–	–	0.03%	234
2022 Q3	$49K	Buy	+120	New	+$44.1K	0.03%	234

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Barrett & Company's IDXX Position: Q2 2026 in Review

Barrett & Company increased its Idexx Laboratories (IDXX) stake by 706% in Q2 2026, buying an estimated $356K and bringing the position to 725 shares worth $382K. The position accounts for 0.11% of the portfolio, ranked #110.

Barrett & Company first reported a position in IDXX in Q3 2022 and has held it in 16 quarters since. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Barrett & Company held 725 shares of Idexx Laboratories worth $382K as of Q2 2026.
Barrett & Company bought 635 Idexx Laboratories shares in Q2 2026, an estimated $356K.
Idexx Laboratories made up 0.11% of Barrett & Company's portfolio in Q2 2026, its #110 holding.
Barrett & Company first reported a position in Idexx Laboratories in Q3 2022 and has held it in 16 quarters since.
1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.